Dr Richard Baird

June 15, 2020

Richard runs a portfolio of early-phase clinical trials that are focused on novel breast cancer therapeutics and biomarker-directed treatment strategies. He is the chief investigator on multiple investigator-initiated trials and is UK Academic Lead for the Association of Cancer Physicians.

Dr Richard Baird
Connect

Connect with us

The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.

Find out more

Connect